BSEBoard Meeting5d ago · 13 Aug 2026, 04:58 pm
Dear Sir/Madam, This is to inform you that pursuant to Regulation 30 of the Listing Regulations, the Board at its meeting held today i.e. Thursday, August 13, 2026, inter alia, considered ....
Deep Health AI India Ltd · 539559
✦ AI SummaryResults
Deep Health AI India Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a draft limited review report. The company's trading window for dealing in shares has been closed for all directors, KMPs, and connected persons from July 1, 2026, and will remain closed for 48 hours after the declaration of the financial results.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Deep Health AI India Ltd - 539559 - Board Meeting Outcome for Submission Of Outcome Of Board Meeting In Compliance With The Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
Attachments (1)
📄pdf
Download →
0fa4a0a7-fa88-4aca-963f-f68ec4e51234.pdf
View document text
DEEP HEALTH AI INDIA LIMITED
(Formerly known as “Deep Diamond India Limited”) CIN: L24100RJ1994PLC112895
Regd. Office: 506-509 fifth floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11,
Udaipur, Rajasthan (313001) Tel: 0294-3569097.
E-mail: deephealthaiindia@gmail.com Website: www.deephealthaiindia.com
Date: August 13, 2026
The Manager,
BSE Limited
Address: Phiroze Jeejeebhoy Towers,
Dalal Street, Fort, Mumbai – 400001.
Scrip Code: 539559
Subject: Submission of Outcome of Board Meeting in compliance with the Regulation 30
of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing
Regulations”).
Dear Sir/Madam,
This is to inform you that pursuant to Regulation 30 of the Listing Regulations, the Board at its
meeting held today i.e. Thursday, August 13, 2026, inter alia, considered and approved the
following:
1. Un-Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026,
along with draft Limited Review Report pursuant to Regulation 33 of the Securities Exchange
and Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Further, the Trading Window for dealing in shares of the Company has already been closed for
all Directors/ KMPs/Designated Employees/ Connected Person of the Company from July 01,
2026, and will remain closed up to 48 (Forty-Eight) hours after the declaration of Un-Audited
Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (both days
inclusive) in accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and the
Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting
of Trading by Insiders.
The Board Meeting commenced at 3:00 P.M and concluded at 3.40 P.M.
Kindly take the same on your records.
FOR DEEP HEALTH AI INDIA LIMITED
(Formerly known as Deep Diamond India Limited)
Narayan Singh Rathore
Managing Director
DIN: 10900646
Place: Udaipur
o/(j{S 'l(&Co. £LP
CHARTERED ACCOUNTANTS
IND I A 1008, Ajmcra Sikova, Opp. Damodar Park, LBS Marg, Ghatkopar (West) Mumbai -400086
Phone: +91-22-35736454 I Mob: +91-9820572292 I Email: sureshkl8@gmail.com
Independent Auditor's Limited Review Report
The Board of Directors,
Deep Health Al India Limited
"We have reviewed the accompanying statement of unaudited quarterly financial results of M/s Deep Health
Al India Limited ('the Company'), for the period ended 30th June, 2026 ('the Statement') being submitted by
the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing obligations and Disclosure
Requirements) Regulations, 2015. This statement which is the responsibility of the Company's Management
and approved by Board of Directors, has been prepared in accordance with the recognition and
measurement principles laid down in Accounting Standard for Interim Financial Reporting (AS 25),
prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued there under and
other accounting principles generally accepted in India. Our responsibility is to issue a report on the
Statement based on our review.
We conducted our review in accordance with the standard on Review Engagements (SRE) 2410, "Review of
Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of
Chartered Accountants of India". This Standard requires that we plan and perform the review to obtain
moderate assurance as to whether the Statements are free of material misstatement. A review is limited
primarily to inquire of Company personnel and analytical procedures applied to financial data and thus
provide less assurance than an audit. We have not performed an audit and accordingly, we do not express
an audit opinion.
Based on our review conducted as above, nothing has come to our attention that causes us to believe that
the accompanying Statement is prepared, in all material aspects, in accordance with applicable accounting
standards prescribed under Section 133 of the Companies Act, 2013 read with rule 7 of the Companies
(Accounts) Rules, 2014 and other recognized accounting practices and policies has not disclosed the
information required to be disclosed in terms of regulation 33 of the SEBI (Listing obligations and Disclosure
Requirements) Regulations 2015 including the manner in which it is to be disclosed, or that it contains any
material misstatement or that it has not been prepared in accordance with the relevant prudential norms
issued by Reserve Bank of India in respect of income recognition, asset classification, provisioning and
other related matters.
For V R S K & CO. LLP
{Formerly known as V.R.S.K.& Co.)
CHARTERED ACCOUNTANTS
Firm~. No: 111426W/W100988
Place Mumbai Suresh G. Kothari
Date August 13, 2026 Partner
UDIN 2604762STSETNNS409 Membership No: 047625
Page I of l
DEEP HEALTH AI INDIA LIMITED
Formerly Known as "DEEP DIAMOND INDIA LIMITED"
Rcgd. Office: 506-509, fifth floor, Apcksha, Plot No.256, Main Road, llirlln Magri, Sector-11, Udalpur, Rafasthan (313001)
CIN: L24100RJ1994PLC1.12895
UNAUDM"ED STA NO ALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH fUNE, 2026
Sr. Particulars ( Rs. in Lakhs)
No. Ouarter ended Year ended
30.06.2026 31.03.2026 30.06.2025 31.03.2026
Unaudited Audited Unaudited Audited
1 Revenue from operations
-Jewellery Business 45 -.00 25 -.00 15 ..0 0 425.00
-Pharmaceutical Business -
2 Other income 45.00 25.00 15.00 425.00
3 Total income (1 +2} 16.61 18.22 18.68 424.02
61.61 43.22 33.68 849.02
4 Expenses
a) Cost of material consumed - - -
b) Purchase of Stock-in-Trade - -
c) Changes in inventories of finished goods work-in-progress - - -
d) a En md p S loto yc ek e - bi en n-T efr ia td s e e xpense - - - -
e) Finance costs 4.81 5.89 4.14 18.81
f) Depreciation 0.70 0.73 0.74 2.71
g) Other expenses 0.12 0.13 0.27 0.78
Total expenses 245.88 13.74 16.06 72.64
65 EPr xo cf ei pt/
i( oL no as ls i)
eb mef so re exceptional items and tax (3-4) (2 15 81 9. .5 91
22 20 ..4 79
12 21. .2 41
759 44 ..9 04
7 Profit/(Loss) before tax (5-6) - 577.84 . (577.84)
8 Tax expenses : (189.901 (555.11) 12.47 176.24
Current tax-current year -
prior year - (103 -.16) 3 -.14 46.33
ProD fie tf /e (r Lre od
t )a fx
rli ta hb eil pit ey r/
o(a ds s (e 7t -)
- - - --
1111 41 320 BPT BRO
ao et
sh sst
ia ee
&&C C
m am
q iin
llupp uudirr
usee
ri ui revv
gpn gn
Plto o
em lm
e se
Sf n ha
/ hg- (
aE a(
ev e
eC p
ae fI
a) n
fu l
tcus e- ee( e
ron )
xt o
R ln
to r
1a ose r/x
e f-
) rp
ie v
te( e9
m+ c1 sh0 )
,,( 44461 14988 (061999 .... .. 18509 1 3200 2 2
41 ,( , ,( 42 674 2 47 05 (75
61 ..
.1. 2
79 50
25 11
1,64
3832 030459 ...... 0554 73 2500 43 (
61 0
42 02
014 69
... ..
79 48
21 :
13 (face value of Rs.1/-each)
(0.13'. (0.48; 0.02 0.14
* Not annualised, except year end basic and diluted EPS
Notes: -
1. T inh ie t sa b mo ev ee t ir ne gs u hl ets ld o of nth 1e 3 C /0o 8m /2p 0a 2n 6y . were reviewed by the Audit Committee and approved by the Board of Directors
2. pF eig ru iore ds / yo ef ath r e p rp er se ev ni to au tis o p ne . riod/year have been regrouped wherever necessary to conform to the current
3. T ish ae p C plo icm ap ba len y to h Ca os mtw po a nb yu .s iness segment, disclosure under Ind AS 108 on "Segment Reporting" issued by the ICAI
For Deep Health AI India Limited
(Formerly known as Deep Diamond India Limited)
Place: Udaipur,
Dated; 13th August, 2026
Narayan Singh Rathore
Managing Director
DIN : 10900646
DEEP HEAL TH AI INDIA LIMITED
Fonnerly Known as "DEEP DIAMOND lNDIA LIMITED"
Rcgd. OOice: 506-509. lifih Ooor, Apcksha. Plot No.256, Main Road, Hirnn Mogri, Sector-I 1. Udaipur, Rojnsthnn (31300 I)
CIN: L24100RJl994PLCI 12895
E-Mail: decphcalthaiindia@gmnil.com Website: www.dccphealthaiindia.com
Segment Reporting (Standalone)
The Company is responsible for Segment reporting as per lndAS -108 "Operating Segment" specified under section 133 of
the Companies Act, 2013. As the Company is engaged in two segments viz. Jewellery of Gold and Diamond S
[Showing first 8,000 characters — download PDF for full document]